Clinical Trials Directory

Trials / Completed

CompletedNCT06581796

Pepsinogen-1 Serum Levels in Hyperemesis Gravidarum

Examination of the Maternal Serum Pepsinogen-1 in Patients Diagnosed With Severe Hyperemesis Gravidarum: A Prospective Case-control Study

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Ankara Etlik City Hospital · Other Government
Sex
Female
Age
21 Years – 35 Years
Healthy volunteers
Accepted

Summary

In this study, the investigators planned to investigate maternal serum pepsinogen-1 (MSPG-1) levels in pregnant women with severe hyperemesis gravidarum (HG) and pregnant women without severe HG. HG is the most common cause of hospitalization in the first trimester of pregnancy and represents an economic burden on the healthcare system. Therefore, our aim in this study was to investigate whether there is a statistical difference in MSPG-1 levels between pregnant women with severe HG and pregnant women without severe HG and to determine a cut-off value for MSPG-1 levels for the indication of hospitalization of pregnant women with HG. The study poses no risk to the pregnant woman or the fetus.

Detailed description

The study will enroll pregnant women in the first trimester with maternal age between 21 and 35 years who were diagnosed with hyperemesis gravidarum and had no fetal congenital or chromosomal abnormalities and who were admitted to the perinatology outpatient clinic of Etlik City Hospital. The investigators will include 40 cases with no signs and diagnosis of systemic maternal disease and no chronic drug use as a case group and 40 healthy pregnant women matched for age, gestational week and body mass index as a control group.

Conditions

Interventions

TypeNameDescription
OTHERpepsinogen-1association between pepsinogen 1 serum level with hyperemesis gravidarum

Timeline

Start date
2024-07-01
Primary completion
2024-09-10
Completion
2024-11-21
First posted
2024-09-03
Last updated
2024-11-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06581796. Inclusion in this directory is not an endorsement.